Cheque Drops 250 mcg
Dragon Pharma

Cheque Drops 250 mcg

Product Information Compound Details
Dragon Pharma
Active Substance Mibolerone 17-alpha-alkylated oral anabolic steroid
250 mcg/tablet
Strength 250 mcg/tablet
Package 100 Tablets 25,000 mcg total labeled content
Form Oral Tablet
Half-Life Approximately 3–4 Hours
Drug Class Androgen & Anabolic Steroid
Manufacturer Dragon Pharma
$99.00
Shipping :
International
U.S. Domestic
Product Overview

Cheque Drops 250 mcg by Dragon Pharma

Cheque Drops 250 mcg is an oral mibolerone tablet manufactured by Dragon Pharma and dosed at 250 mcg per tablet in a 100-tablet package.

Mibolerone Oral

Cheque Drops 250 mcg contains mibolerone, a synthetic anabolic-androgenic steroid that is orally active and exceptionally potent. Mibolerone is a 17-alpha-alkylated nandrolone derivative, a structural modification that allows it to survive first-pass metabolism and remain bioavailable when taken orally. Its potency relative to testosterone has been described as significantly higher on both anabolic and androgenic scales.

In its original veterinary context, mibolerone was approved for prevention of estrus in adult female dogs. It is not approved for human use in the United States. In non-medical bodybuilding and strength-sport contexts, mibolerone is referenced almost exclusively for acute central nervous system activation and aggression enhancement prior to training or competition, rather than for muscle-building over time. Its extremely short half-life of approximately 3–4 hours means it does not accumulate in the body and is not suitable for traditional bulking or cutting cycles.

Mibolerone binds with high affinity to both androgen and progesterone receptors, which contributes to its strong androgenic and progestogenic activity. This dual receptor activity distinguishes it from many other anabolic steroids and underlies both its potent effects and its significant risk profile. Non-medical use falls outside approved indications, and the compound is widely regarded as one of the most toxic oral steroids available.

Key Benefits of Cheque Drops 250 mcg

  • Rapid central nervous system activation within 30–60 minutes
  • Acute increase in aggression and competitive drive
  • Enhanced pain tolerance and mental focus
  • Very short half-life for rapid clearance
  • 250 mcg tablet strength for precise pre-workout dosing
Product Profile

Mibolerone Profile

Mibolerone is a 17-alpha-alkylated nandrolone derivative characterized by extreme androgen receptor affinity, a very short half-life, and a dual androgenic-progestogenic receptor binding profile.

High-Potency Oral Androgen

Mibolerone is structurally classified as 7-alpha,17-alpha-dimethyl-19-nortestosterone, a nandrolone derivative with two methyl groups that confer oral activity and resistance to metabolic breakdown. Its binding affinity for the androgen receptor in human prostate tissue has been measured at approximately 1.5 nM, which is higher than that of R1881, a commonly used reference androgen.

The compound also binds with high affinity to the progesterone receptor, a characteristic it shares with nandrolone and other 19-nor steroids. This progestogenic activity means that while mibolerone does not aromatize to estrogen, it can still contribute to progestin-related side effects such as gynecomastia sensitization and suppressed libido.

Mibolerone is not used in bodybuilding for its anabolic effects at practical doses. The doses required for meaningful anabolic activity would be far beyond what the body can tolerate due to hepatotoxicity. Instead, it is used acutely at low microgram doses to exploit its central nervous system effects.

Defining Characteristic

Acute CNS Activation with Very Short Half-Life

Mibolerone is distinguished by its rapid onset of central nervous system effects and its short half-life of approximately 3–4 hours. These properties make it unsuitable for sustained cycles but relevant in acute pre-event contexts.

Cheque Drops 250 mcg vs Other Dragon Pharma Preparations

Dragon Pharma offers a range of oral and injectable anabolic preparations with fundamentally different applications. Mibolerone's acute aggression-enhancing profile contrasts sharply with compounds intended for sustained muscle growth, such as Dianabol 50, which aromatizes and supports mass gains over weeks. For users seeking a non-aromatizing oral for lean muscle preservation over a cycle, Anavar 50 offers a fundamentally different and substantially safer profile. Halotestin is another potent oral androgen sometimes referenced for strength and aggression, though its effects are more sustained than those of mibolerone.

The distinction between mibolerone and these compounds is not one of degree but of kind: mibolerone is not a cycle compound in any conventional sense.

Dosage & Usage

Cheque Drops 250 mcg Dosage & Usage

The information below is provided for educational reference only. Mibolerone is not approved for human use in the United States and is a controlled substance. Non-medical use falls outside approved indications and carries substantial health risks.

Typical Dosage Ranges

Mibolerone dosage in non-medical contexts is expressed in micrograms, not milligrams. Common reference points in bodybuilding and strength-sport discussion center on acute pre-workout or pre-event administration rather than daily cycling. A single 250 mcg tablet corresponds to typical referenced doses of 1–2 tablets taken 30–60 minutes before training.

Use Case Common Reference Range Frequency
Pre-workout (non-medical) 200–500 mcg 30–60 minutes before training
Pre-competition (non-medical) 250–500 mcg Single dose before event
Weekly exposure limit (non-medical) Not to exceed 2–3 sessions Due to hepatotoxicity and toxicity

Stacking & Cycle Considerations

Mibolerone is not a compound that is stacked in the conventional sense. In non-medical contexts where it is referenced, it is typically used as an isolated pre-workout agent alongside an ongoing anabolic cycle, rather than as part of that cycle itself. Because it suppresses luteinizing hormone secretion and is severely hepatotoxic, it is not appropriate for extended use, and most discussion limits exposure to isolated sessions or short windows of no more than two weeks.

For users running a conventional cycle with compounds such as Testabol 400, mibolerone would not be integrated into the cycle structure but rather used sparingly on specific training days where an acute boost is desired.

Managing Side Effects

Mibolerone does not aromatize, so aromatase inhibitors are not relevant for managing its effects. However, its strong progestogenic activity means that prolactin-related side effects are a concern, and its 17-alpha-alkylated structure creates substantial liver stress. Liver support and avoidance of other hepatotoxic compounds are paramount. Blood pressure and lipid profile can be adversely affected even with short-term use.

Psychological effects including extreme aggression, mood swings, and irritability are commonly reported and can affect judgment and interpersonal behavior.

Post-Cycle Therapy (PCT)

Because mibolerone is not used as a cycle compound, traditional PCT is not structured around it. However, its suppression of endogenous testosterone production means that if it is used, recovery of natural hormone function should be considered. Agents such as Clomid or Nolvadex are commonly referenced for post-suppression recovery in broader anabolic contexts, though mibolerone-specific recovery protocols are not well characterized.

Important

Individual Response Varies

Mibolerone is an exceptionally potent and toxic compound. The information above is for educational reference and does not constitute medical advice. Non-medical use is strongly cautioned against.

Safety & Information

Mibolerone Safety Information

Mibolerone is a veterinary-only anabolic steroid in the United States and is not approved for human use. It is associated with severe hepatotoxicity, psychological effects, and cardiovascular strain.

Important Safety Information

Mibolerone is approved by the FDA only for oral use in adult female dogs for prevention of estrus. It has no approved human indication. The compound is a Schedule III controlled substance in the United States.

Mibolerone is a 17-alpha-alkylated steroid, a structural class associated with significant hepatotoxicity. Prolonged or repeated exposure can lead to elevated liver enzymes, cholestasis, hepatic inflammation, and potentially liver failure.

Important

Non-Medical Use

Mibolerone is not approved for human use. Non-medical use falls outside approved indications and carries risks that are substantially greater than those of most other anabolic steroids. Product strength and formulation do not establish safety for human consumption.

Potential Adverse Effects

Hepatotoxicity: As a 17-alpha-alkylated compound, mibolerone places significant stress on liver cells. Elevated ALT and AST, cholestasis, and hepatic inflammation are documented concerns with this class of steroids.

Androgenic effects: Mibolerone has very high androgen receptor affinity, which can accelerate male-pattern hair loss, increase sebum production and acne, and cause virilization in women including voice deepening and hirsutism.

Psychological effects: Aggression, mood swings, irritability, and emotional instability are commonly reported. These effects stem from androgen receptor activation in brain regions involved in aggression and impulse control.

Cardiovascular effects: Mibolerone can decrease HDL cholesterol, increase LDL cholesterol, elevate blood pressure, and increase red blood cell count, collectively increasing cardiovascular risk.

Progestogenic effects: Despite not aromatizing, mibolerone binds the progesterone receptor and can contribute to gynecomastia sensitization, suppressed libido, and prolactin-related effects.

Endocrine suppression: Mibolerone suppresses luteinizing hormone and follicle-stimulating hormone, leading to reduced endogenous testosterone production, testicular atrophy, and potential fertility impairment.

Conditions Requiring Medical Evaluation

Given the severity of potential adverse effects, any consideration of mibolerone exposure warrants comprehensive medical evaluation including liver function tests, lipid panel, blood pressure assessment, and hormonal evaluation. Individuals with pre-existing liver disease, cardiovascular disease, or psychiatric conditions are at heightened risk.

Mibolerone is not appropriate for women due to virilization risk, or for individuals planning to have children due to suppression of reproductive function.

Monitoring During Therapy

There is no established monitoring protocol for non-medical mibolerone use. In veterinary contexts, monitoring is limited to the approved indication. For any human exposure, liver function, lipid profile, blood pressure, and hormonal status should be assessed by a qualified healthcare professional.

Product Care

Storage & Handling

Store in a cool, dry place away from direct light and moisture. Keep the product in its original packaging and out of the reach of children. This product is not for human consumption.

Further Safety Information
Shipping & Authenticity

Shipping & Product Authenticity

Cheque Drops 250 mcg is supplied through the Dragon Pharma distribution chain and shipped in original manufacturer packaging with discreet, privacy-focused handling.

USA Domestic 3–5 business days
International 10–15 business days
Order Processing 24–48 business hours
Tracking Provided after dispatch
Direct Supply

Discreet Delivery & Original Packaging

The outer shipping package remains discreet, with privacy-focused handling and no unnecessary external product details.

What to Expect

  • Orders are processed after payment confirmation
  • USA Domestic shipping is typically faster when local stock is selected
  • International orders include tracking, though update frequency may vary by destination
  • Multiple warehouses may result in separate shipments when applicable

Authenticity Verification

To verify your Cheque Drops 250 mcg product, cross-check the security features on the packaging against Dragon Pharma's official presentation. Original packaging helps reinforce product legitimacy.

For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.

Storage

Cheque Drops 250 mcg Storage

Proper storage conditions help preserve tablet integrity and overall product stability throughout shelf life.

Recommended Conditions

Store in a cool, dry place away from excessive heat, moisture, and direct light. Maintaining stable conditions helps preserve the integrity of the tablets.

Keep the tablets in their original packaging until use. Do not use if the packaging appears compromised or if the tablets show signs of degradation such as discoloration or crumbling.

Keep out of reach of children. This product is not for human consumption.

Quick Reference

Do & Don't

  • Do store in a cool, dry place
  • Do keep in original packaging
  • Do inspect tablets before use
  • Don't expose to direct sunlight
  • Don't store in humid environments
  • Don't use if tablets appear abnormal
Frequently Asked Questions

Cheque Drops 250 mcg FAQ

Answers to common questions about Cheque Drops 250 mcg, mibolerone, its acute effects, dosage, and safety profile.

What is Cheque Drops 250 mcg used for?

In veterinary medicine, mibolerone is approved for prevention of estrus in adult female dogs. In non-medical bodybuilding and strength-sport contexts, Cheque Drops 250 mcg is referenced almost exclusively for acute pre-workout or pre-competition use to enhance aggression, focus, and pain tolerance. It is not used for muscle-building over time.

How often should Cheque Drops 250 mcg be taken?

In non-medical contexts, mibolerone is referenced for isolated use 30–60 minutes before a training session or event, typically no more than 2–3 times per week due to its extreme toxicity. It is not a daily-use compound and should not be taken in extended cycles.

Does Cheque Drops 250 mcg require PCT?

Mibolerone is not used as a cycle compound, so traditional PCT is not structured around it. However, it does suppress luteinizing hormone secretion and endogenous testosterone production. If used, recovery of natural hormone function should be considered, and agents such as Clomid or Nolvadex are commonly referenced for post-suppression recovery in broader contexts.

What does mibolerone do?

Mibolerone is an extremely potent androgen that binds with high affinity to androgen receptors and also to progesterone receptors. Its primary acute effects are central nervous system activation, increased aggression, and enhanced pain tolerance. It is not used for anabolic purposes at practical doses because the required doses would be severely hepatotoxic.

How long does mibolerone take to work?

Mibolerone has a very rapid onset. In non-medical contexts, users typically report effects within 30–60 minutes of oral administration. Its half-life is approximately 3–4 hours, so effects are short-lived and do not accumulate with repeated dosing.

Is mibolerone the strongest steroid?

Mibolerone is frequently described as one of the most potent androgens known, with high androgen receptor affinity. However, "strongest" depends on the criterion being measured. It is exceptionally potent in terms of receptor binding and CNS effects, but it is not used for anabolic purposes because its toxicity profile makes practical anabolic dosing impossible.

What is the difference between mibolerone and halotestin?

Both are potent oral androgens, but they have different applications. Halotestin (fluoxymesterone) is sometimes used in short cycles for strength and aggression, while mibolerone is used for acute, single-dose pre-workout effects. Mibolerone has a much shorter half-life and is generally considered more toxic.

What is the difference between mibolerone and trenbolone?

Trenbolone is an injectable 19-nor steroid used in cycles for significant muscle growth and strength gains over weeks. Mibolerone is an oral 17-alpha-alkylated 19-nor steroid used for acute effects lasting hours. They share a 19-nor structure but have fundamentally different applications and risk profiles. Dragon Pharma offers Trenbolone 100 as an injectable alternative with a different use case entirely.

Is 250 mcg of mibolerone a lot?

In veterinary use, mibolerone is dosed in micrograms, with 30–180 mcg daily for dogs depending on weight. In non-medical human contexts, 250 mcg corresponds to a typical single pre-workout dose, which is already a significant exposure given the compound's potency. There is no safe human dose of mibolerone.

What strength is Cheque Drops 250 mcg?

Cheque Drops 250 mcg is labeled at 250 micrograms of mibolerone per tablet. It is supplied in a 100-tablet package, giving 25,000 mcg of total labeled content.

Is mibolerone approved for human use?

No. Mibolerone is approved by the FDA only for veterinary use in adult female dogs for prevention of estrus. It has no approved human indication in the United States and is a controlled substance.

No reviews found

Please log in to write Cheque Drops 250 mcg review.

Related Offers
Lab Tested
Domestic & International
Cypionat 250 mg
Dragon Pharma, Europe
Product Information Compound Details
Dragon Pharma
Active Substance Testosterone Cypionate Long-acting testosterone ester
250 mg/mL
Strength 250 mg/mL
Package 10 mL Vial 2,500 mg total labeled content
Form Oil-Based Injectable (MCT Oil)
Estimated Half-Life Approximately 8 Days
Drug Class Androgen & Anabolic Steroid
Manufacturer Dragon Pharma
Latest Laboratory Result 277.11 mg/mL March 20, 2026 · 110.84% of label claim View
$53.00
Lab Tested
Domestic & International
-50% OFF
Dianabol 20 mg
Dragon Pharma, Europe
Product Information Compound Details
Dragon Pharma
Active Substance Methandienone 17-alpha-alkylated oral anabolic steroid
20 mg/tablet
Strength 20 mg/tablet
Package 100 Tablets 2,000 mg total labeled content
Form Oral Tablet
Half-Life Approximately 3–6 Hours
Drug Class Androgen & Anabolic Steroid
Manufacturer Dragon Pharma
Latest Laboratory Result 20.85 mg April 18, 2025 · 104.25% of label claim View
$28.50 $57.00
You will save $28.50
Lab Tested
Domestic & International
-50% OFF
Winstrol 50 mg
Dragon Pharma, Europe
Product Information Compound Details
Dragon Pharma
Active Substance Stanozolol 17-alpha-alkylated oral anabolic steroid
50 mg/tablet
Strength 50 mg/tablet
Package 100 Tablets 5,000 mg total labeled content
Form Oral Tablet
Half-Life Approximately 9 Hours
Drug Class Androgen & Anabolic Steroid
Manufacturer Dragon Pharma
Latest Laboratory Result 48.62 mg April 18, 2025 · 97.24% of label claim View
$40.00 $80.00
You will save $40.00
Lab Tested
Shipped USA Domestic
-40% OFF
Ment 50 mg
Dragon Pharma, Europe
Product Information Compound Details
Dragon Pharma
Active Substance Trestolone Acetate Potent 19-nor testosterone derivative (MENT)
50 mg/mL
Strength 50 mg/mL
Package 10 mL Vial 500 mg total labeled content
Form Oil-Based Injectable
Carrier MCT Oil
Drug Class Anabolic Androgenic Steroid (19-nor)
Manufacturer Dragon Pharma
Latest Laboratory Result 51.36 mg March 21, 2024 · 102.72% of label claim View
$87.00 $145.00
You will save $58.00

Add to Cart - Product(s)

Close Button
Empty

Total Cost: